Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver Disease

NCT04235205 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

102

Enrollment

OTHER

Sponsor class

Conditions

Nonalcoholic Fatty Liver
Nonalcoholic Steatohepatitis

Interventions

DRUG: Elobixibat 10mg + cholestyramine powder 9g (cholestyramine 4g)
DRUG: Elobixibat 10mg + cholestyramine powder placebo
DRUG: Elobixibat placebo + cholestyramine powder 9g (cholestyramine 4g)
DRUG: Elobixibat placebo + cholestyramine powder placebo

Sponsor

Yokohama City University

Collaborators

[object Object]